A Mechanistic Study of the Effect of Doxorubicin/Adriamycin on the Estrogen Response in a Breast Cancer Model

Publisher： Karger

E-ISSN： 1423-0232|83|6|305-320

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.6, 2012-09, pp. : 305-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal doxorubicin in breast cancer

By Shehata M   Mukherjee A   Sharma R   Chan S  

Women's Health, Vol. 3, Iss. 5, 2007-09 ,pp. : 557-569

Future Medicine

Access to resources Recommend Favorite

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-12 ,pp. : 840-846

Karger

Access to resources Recommend Favorite

Estrogen Receptors: Role in Breast Cancer

By Duffy M.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 325-347

Informa Healthcare

Access to resources Recommend Favorite

Phase II Study of Concurrent Administration of Doxorubicin and Docetaxel as First-Line Chemotherapy for Metastatic Breast Cancer

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 124-130

Karger

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 147-151

Karger

Access to resources Recommend Favorite